'Sometimes I get goosebumps,' says Bharat Biotech MD as firm preparing for Covaxin rollout3 min read 22 Dec 2020, 02:16 PM IST
Bharat Biotech has already produced about 10 million doses of its Covaxin shot
Bharat has spent about $60 million to $70 million so far developing coronavirus vaccines
The developer of India’s leading indigenous coronavirus vaccine is already producing millions of doses of its yet-to-be-approved candidate, but the thought of supplying enough shots for half the country’s nearly 1.4 billion people can seem daunting at times.
Select your Category